1 line
6.2 KiB
JSON
1 line
6.2 KiB
JSON
{"abdominal tenderness": 2.6, "acute graft versus host disease": 6.13, "acute graft versus host disease in skin": 6.75, "acute lymphocytic leukaemia": 27.38, "acute lymphocytic leukaemia recurrent": 45.78, "acute myeloid leukaemia": 23.82, "acute myeloid leukaemia recurrent": 200.66, "acute promyelocytic leukaemia": 18.13, "acute respiratory distress syndrome": 5.27, "acute respiratory failure": 2.16, "adenovirus infection": 9.47, "agranulocytosis": 3.19, "alpha haemolytic streptococcal infection": 47.09, "anaemia": 2.5, "aplastic anaemia": 5.16, "appendicitis": 4.75, "ascites": 2.92, "aspergillus infection": 19.33, "atelectasis": 3.32, "b-cell lymphoma recurrent": 54.33, "bacteraemia": 17.37, "bacterial infection": 11.4, "bacterial sepsis": 13.86, "bk virus infection": 7.67, "blast crisis in myelogenous leukaemia": 16.46, "blood bilirubin increased": 2.81, "blood culture positive": 13.78, "blood disorder": 11.43, "blood lactate dehydrogenase increased": 8.55, "bone marrow failure": 21.51, "bronchopulmonary aspergillosis": 23.24, "burkitt's lymphoma": 42.46, "c-reactive protein increased": 2.3, "candida infection": 5.97, "cardiomyopathy": 4.79, "cardiotoxicity": 13.73, "central nervous system lymphoma": 75.57, "chloroma": 50.53, "chronic graft versus host disease": 4.68, "chronic myeloid leukaemia": 3.76, "clostridium difficile colitis": 5.35, "clostridium difficile infection": 5.04, "coagulopathy": 2.38, "colitis": 4.12, "congenital aplasia": 23.24, "covid-19 pneumonia": 2.03, "cystitis haemorrhagic": 8.81, "cytogenetic abnormality": 26.64, "cytokine release syndrome": 3.87, "cytomegalovirus chorioretinitis": 26.63, "cytomegalovirus infection": 6.25, "cytomegalovirus infection reactivation": 12.32, "cytomegalovirus viraemia": 6.07, "cytopenia": 22.4, "device related infection": 2.66, "device related sepsis": 12.2, "differentiation syndrome": 37.51, "diffuse large b-cell lymphoma": 35.22, "diffuse large b-cell lymphoma recurrent": 176.89, "diffuse large b-cell lymphoma refractory": 179.84, "disease progression": 13.65, "disease recurrence": 5.69, "disseminated intravascular coagulation": 5.1, "drug resistance": 4.27, "encephalitis": 2.13, "encephalopathy": 2.15, "enteritis": 3.09, "enterobacter infection": 54.01, "enterococcal infection": 13.33, "enterovirus infection": 52.25, "escherichia bacteraemia": 35.63, "escherichia infection": 15.71, "escherichia sepsis": 17.16, "febrile bone marrow aplasia": 22.89, "febrile neutropenia": 49.84, "foetal growth restriction": 2.57, "follicular lymphoma": 22.99, "full blood count decreased": 3.91, "fungaemia": 23.4, "fungal infection": 7.83, "fusarium infection": 45.7, "gastrointestinal inflammation": 6.98, "gene mutation": 11.0, "geotrichum infection": 261.33, "graft versus host disease": 6.63, "granulocyte count decreased": 14.93, "granulocytopenia": 12.37, "haematotoxicity": 11.3, "haemoglobin abnormal": 21.83, "haemoglobin decreased": 3.27, "haemophagocytic lymphohistiocytosis": 10.0, "hepatic failure": 2.02, "hepatitis b": 4.54, "hepatitis b reactivation": 6.02, "hepatomegaly": 2.73, "hepatosplenomegaly": 5.65, "hepatotoxicity": 2.36, "herpes simplex": 3.37, "human herpesvirus 6 infection": 22.04, "human herpesvirus 6 infection reactivation": 31.36, "hydronephrosis": 3.89, "hyperbilirubinaemia": 8.4, "hypertransaminasaemia": 3.18, "hypertriglyceridaemia": 2.35, "hypoalbuminaemia": 3.59, "hypogammaglobulinaemia": 26.0, "hypoxia": 2.82, "ileus": 2.56, "ill-defined disorder": 2.57, "immune effector cell-associated neurotoxicity syndrome": 3.21, "immunodeficiency": 2.3, "infection": 6.59, "infection in an immunocompromised host": 74.45, "intestinal perforation": 2.36, "klebsiella infection": 15.12, "klebsiella sepsis": 31.52, "leukaemia": 3.02, "leukaemia recurrent": 40.04, "leukocytosis": 2.21, "leukoencephalopathy": 19.33, "leukopenia": 3.45, "low birth weight baby": 2.24, "lung infiltration": 2.43, "lymphocyte count decreased": 3.21, "lymphoma": 4.07, "maligt neoplasm progression": 2.46, "mantle cell lymphoma": 35.89, "mantle cell lymphoma recurrent": 106.19, "minimal residual disease": 43.29, "mucormycosis": 32.04, "mucosal inflammation": 20.4, "multiple organ dysfunction syndrome": 7.09, "myelodysplastic syndrome": 18.94, "myelopathy": 23.04, "myelosuppression": 28.73, "neoplasm": 3.59, "neoplasm progression": 3.63, "neoplasm recurrence": 19.68, "nephropathy toxic": 2.27, "nervous system disorder": 2.54, "neuropathy peripheral": 2.34, "neurotoxicity": 5.23, "neutropenia": 6.92, "neutropenic colitis": 57.93, "neutropenic infection": 67.36, "neutropenic sepsis": 28.22, "neutrophil count decreased": 6.2, "non-hodgkin's lymphoma": 8.1, "odynophagia": 2.45, "oesophagitis": 2.02, "off label use": 3.47, "osteonecrosis": 2.04, "pancytopenia": 10.68, "parainfluenzae virus infection": 38.24, "paraplegia": 4.78, "pathogen resistance": 3.38, "peripheral sensory neuropathy": 3.25, "platelet count decreased": 4.69, "platelet count increased": 2.91, "pleural effusion": 3.17, "pneumocystis jirovecii pneumonia": 6.74, "pneumonia": 2.14, "pneumonia cytomegaloviral": 16.84, "pneumonia fungal": 27.26, "posterior reversible encephalopathy syndrome": 13.31, "premature baby": 2.12, "premature delivery": 9.12, "product use in unapproved indication": 3.78, "progressive multifocal leukoencephalopathy": 6.29, "pseudomonal sepsis": 15.23, "pseudomonas infection": 10.72, "pulmonary haemorrhage": 4.77, "pulmonary mass": 2.98, "refractory cancer": 191.74, "respiratory failure": 3.37, "rhinovirus infection": 22.26, "second primary maligcy": 14.03, "sepsis": 7.98, "septic shock": 13.91, "sinus tachycardia": 2.57, "skin lesion": 2.0, "splenomegaly": 4.06, "staphylococcal bacteraemia": 15.47, "staphylococcal infection": 4.47, "staphylococcal sepsis": 13.01, "stenotrophomonas infection": 39.07, "stomatitis": 3.27, "streptococcal bacteraemia": 50.38, "streptococcal sepsis": 32.95, "systemic candida": 21.35, "therapeutic product effect incomplete": 4.01, "therapeutic response decreased": 2.44, "therapy non-responder": 5.51, "therapy partial responder": 12.47, "thrombocytopenia": 5.36, "treatment failure": 3.21, "tumour lysis syndrome": 17.38, "varicella zoster virus infection": 6.62, "venoocclusive disease": 18.17, "venoocclusive liver disease": 23.96, "white blood cell count abnormal": 7.47, "white blood cell count decreased": 4.75, "white matter lesion": 19.41} |